In gastric cancer, high PBX3 expression leads to the decrease in E-cadherin expression and increase in N-cadherin, vimentin, and MMP-9 expression by promoting EMT via AKT signaling pathway [112,113]. The gene discussed is CDH2; the disease is gastric cancer.